CoChat

Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study

Open access
Wang, Wei, Xie, Xin, Yuan, Ting, Wang, Yanyan, Zhao, Fei, Zhou, Zhangjian, Zhang, Hao · 2021 · BMC Pregnancy and Childbirth

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 5 of the 34 sources its claims cite were checked for support.

Abstract

Background: Relevant studies focusing on epidemiological of profiles hypertensive disorders of pregnancy from global data that report the cause-specific prevalence and trends of hypertensive disorders of pregnancy at global, regional and national levels from 1990 to 2019 by age and sociodemographic index are still limited. Methods: For hypertensive disorders of pregnancy, point prevalence, annual incidence, and years lived with disability numbers and age standardized rates per 100,000 population were compared at regional and national levels by age and sociodemographic index using data from the global Burden of Disease 2019 Study, covering populations from 204 countries and territories. Estimates are reported with uncertainty intervals to exhibit the changing trends during a specific period. Results: The incidence of hypertensive disorders of pregnancy increased from 16.30 million to 18.08 million globally, with a total increase of 10.92 % from 1990 to 2019. The age-standardized incidence rate decreased, with an estimated annual percent change of -0.68 (95 % confidence interval [CI] -0.49 to -0.86). The number of deaths due to hypertensive disorders of pregnancy was approximately 27.83 thousand in 2019, representing a 30.05 % decrease from 1990. Based on the incidence and prevalence, the number of deaths and years lived with disability were highest in the group aged 25–29 years, followed by the groups aged 30–34 and 20–24 years, while the lowest estimated incidence rate was observed in the group aged 25–29 years and higher incidence rates were observed in the youngest and oldest groups. Positive associations between incidence rates and the sociodemographic index and human development index were found for all countries and regions in 2019. Age-standardized incidence rates were higher in countries/regions with lower sociodemographic indices and human development indices. Conclusions: Our study provides a comprehensive overview of the global burden of hypertensive disorders of pregnancy. The death and incidence rates are decreasing in most countries and all regions except for those with low sociodemographic and human development indexes. This difference is mainly due to the increasing attention to prenatal examinations and health education. Further investigations should focus on forecasting the global disease burden of specific hypertensive disorders of pregnancy and modifiable risk factors.

Overview

CoChat Summary

TL;DR

Using GBD 2019 data from 204 countries and territories, this study describes global, regional, and national trends in hypertensive disorders of pregnancy (HDP) from 1990 to 2019. Although the absolute number of incident cases rose 10.92%, age-standardized incidence and death rates declined overall, with the highest burden concentrated in low-SDI/HDI countries and in sub-Saharan Africa and South Asia.

Key findings

  • Global incident cases increased from 16.30 million (95% UI 13.56–19.42 million) in 1990 to 18.08 million (95% UI 15.26–21.11 million) in 2019, a 10.92% increase; the age-standardized incidence rate (ASIR) fell from 579 to 463 per 100,000, with an EAPC of −0.68 (95% CI −0.49 to −0.86).
  • Deaths due to HDP were approximately 27.83 thousand in 2019, a 30.05% decrease from 1990; the EAPC of the age-standardized death rate was −2.38 (95% CI 1.67 to −6.27).
  • In 2019, the highest regional incidence was in South Asia (3.84 million), western sub-Saharan Africa (3.71 million), and eastern sub-Saharan Africa (3.12 million); the highest ASIRs were in western, central, and eastern sub-Saharan Africa, while the lowest were in East Asia, high-income Asia Pacific, and Central Europe.
  • National ASIRs ranged from 36.34 to 2278.25 per 100,000; Chad (2278.25), Niger (2256.95), and Somalia (2251.26) had the highest estimates, while Korea (36.34), Canada (49.13), and Luxembourg (58.27) had the lowest. Counts were highest at ages 25–29, followed by 30–34 and 20–24, but estimated incidence among pregnant women was lowest at 25–29 and higher at the youngest and oldest ages; ASIRs were higher in countries/regions with lower SDI and HDI.

Methods

  • Population-based analysis of GBD 2019 data covering 204 countries and territories from 1990 to 2019; prevalence, incidence, death, DALYs, YLDs, YLLs, age-standardized rates, and attributable risk factors were extracted from the Global Health Data Exchange, with SDI quintiles and HDI data from the Human Development Report 2019.
  • The number of pregnant women was estimated as live births plus 15% of live births for stillbirths/miscarriages.
  • Estimated annual percentage changes (EAPCs) were calculated using a generalized linear model with a Gaussian distribution for ASRs and a log-linear trend assumption; uncertainty intervals were based on 1,000 draws using the 2.5th and 97.5th centiles, with analyses in Excel 2019 and R 4.0.0.

Limitations

  • The paper states that only iron deficiency from the behavioral risk category could be analyzed as an HDP risk factor, while GBD data on body mass index, maternal age, preexisting diseases, lipid metabolism, and air pollution were limited or unavailable for HDP analysis.
  • The paper notes controversy about iron supplementation and HDP, with inconsistent findings potentially explained by different methodologies and gestational times of serum sample collection.
  • Evident from the text: estimates are modeled GBD 2019 data with uncertainty intervals rather than a primary cohort; age-specific incidence based on all women versus estimated pregnant women changes the age pattern, and the paper’s wording on SDI/HDI associations is internally inconsistent—it reports positive associations while also stating that ASIRs were higher in lower SDI/HDI countries.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s12884-021-03809-2

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Overview of HDP by country and region for both sexes combined. a The prevalence of HDP in 2019. b The ASIR of HDP per 100,000 population in 2019. c The EAPC in the ASDR of HDP from 1990 to 2019. The map depicted in this figure is our own. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; EAPC, estimated annual percentage change; HDP, hypertensive disorders of pregnancy
Fig. 1 Overview of HDP by country and region for both sexes combined. a The prevalence of HDP in 2019. b The ASIR of HDP per 100,000 population in 2019. c The EAPC in the ASDR of HDP from 1990 to 2019. The map depicted in this figure is our own. ASIR, age-standardized incidence rate; ASDR, age-standardized death rate; EAPC, estimated annual percentage change; HDP, hypertensive disorders of pregnancyCC BY · PubMed Central
Fig. 2 Global number of cases and ASRs per 100,000 population stratified by age in 2017. aThe global number of deaths and ASDRs. b The global number of deaths and eASDR. c The global number of incident cases and ASIR. d The global number of incident cases and eASIR. e The global number of prevalence cases and ASPR. f The global number of prevalent cases and eASPR. g The global number of YLDs and ASR of YLDs. h The global number of YLDs and eASR of YLDs. ASIR, age-standardized incidence rate; eASIR, estimated age-standardized incidence rate according to the number of pregnant women; ASDR, age-standardized death rate; eASDR, estimated age-standardized death rate according to the number of pregnant women; ASPR, age-standardized prevalence rate; eASPR, estimated age-standardized prevalence rate according to the number of pregnant women; ASR, age-standardized rate; eASR, estimated age-standardized rate according to the number of pregnant women; YLDs, years lived with disability
Fig. 2 Global number of cases and ASRs per 100,000 population stratified by age in 2017. aThe global number of deaths and ASDRs. b The global number of deaths and eASDR. c The global number of incident cases and ASIR. d The global number of incident cases and eASIR. e The global number of prevalence cases and ASPR. f The global number of prevalent cases and eASPR. g The global number of YLDs and ASR of YLDs. h The global number of YLDs and eASR of YLDs. ASIR, age-standardized incidence rate; eASIR, estimated age-standardized incidence rate according to the number of pregnant women; ASDR, age-standardized death rate; eASDR, estimated age-standardized death rate according to the number of pregnant women; ASPR, age-standardized prevalence rate; eASPR, estimated age-standardized prevalence rate according to the number of pregnant women; ASR, age-standardized rate; eASR, estimated age-standardized rate according to the number of pregnant women; YLDs, years lived with disabilityCC BY · PubMed Central
Fig. 3 ASIRs of HDP by country and region and (a) SDIs (with 204 countries and regions) and (b) HDIs (with 187 countries and regions) in 2019. Each point shows the observed ASIR for a specified country or region in 2019. The red circle includes the 10 countries or regions with the highest ASIRs. The blue circle includes the 10 countries or regions with the lowest ASIRs. ASIR, age-standardized incidence rate; HDP, hypertensive disorders of pregnancy; HDI, human development index; SDI, sociodemographic index
Fig. 3 ASIRs of HDP by country and region and (a) SDIs (with 204 countries and regions) and (b) HDIs (with 187 countries and regions) in 2019. Each point shows the observed ASIR for a specified country or region in 2019. The red circle includes the 10 countries or regions with the highest ASIRs. The blue circle includes the 10 countries or regions with the lowest ASIRs. ASIR, age-standardized incidence rate; HDP, hypertensive disorders of pregnancy; HDI, human development index; SDI, sociodemographic indexCC BY · PubMed Central

Verification

Claims the paper makes

4 Valid · 1 Not valid · 22 Not checked · 46 Own results and interpretations

13 more claims

Create a free account to see all 73 claims and to verify the 29 references still open.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 36

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 8 · the rest aren’t loaded

3 more findings

Create a free account to see every finding of this check.

See all findings — free account

Citations

Cites

Show all 32 references

Cited by

See all 381

Metadata

Authors
Wang, W., Xie, X., Yuan, T., Wang, Y., Zhao, F., Zhou, Z., & Zhang, H.
Affiliations
  • First Affiliated Hospital of Xi'an Jiaotong University (CN)
  • Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Corresponding author
Zhang, Hao
Venue
BMC Pregnancy and Childbirth
Published
2021-05-08
Volume
21
Issue
1
Pages
364-364
ISSN
1471-2393 (ISSN-L)
OpenAlex
W3126544253
Cited by
381
References
32
Citations by year
2026: 69 · 2025: 97 · 2024: 79 · 2023: 82 · 2022: 51 · 2021: 3
FWCI
48.99
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Pregnancy and Childbirth (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
World Health Organization
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
  • Health Sciences › Medicine › Clinical Neurology › Neurological Complications and Syndromes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
Keywords
hypertensive disorders of pregnancy, preeclampsia, maternal morbidity, incidence trends, years lived with disability, maternal mortality, socio-demographic index, Human Development Index, age-standardized incidence, global burden of disease, prenatal care
MeSH terms
Female, Humans, Pregnancy, Socioeconomic Factors, Global Health, Incidence, Hypertension, Pregnancy-Induced

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. https://app.cochat.ai/papers/10.1186/s12884-021-03809-2
The paper
Wang, W., Xie, X., Yuan, T., Wang, Y., Zhao, F., Zhou, Z., & Zhang, H. (2021). Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: a population‐based study. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-021-03809-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.